HDEF - ETF AI Analysis
Top Page
Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)
HDEF, the Xtrackers MSCI EAFE High Dividend Yield Equity ETF, earns a solid overall rating thanks to strong, diversified holdings like Novartis, TotalEnergies, Roche, and DBS Group, which combine solid financial performance, attractive dividends, and generally positive business outlooks. However, some holdings such as Allianz and Unilever show bearish or cautious technical signals and valuation concerns, and the fund’s sizable positions in a few large companies and sectors mean investors should be aware of concentration risk in major non-U.S. dividend payers.
HDEF vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.34B
- Region
- Developed Markets
- Expense Ratio
- 0.09%
- Beta
- 0.35
- Issuer
- Xtrackers
- Inception Date
- Aug 12, 2015
- Dividend Yield
- 3.69%
- Asset Class
- Equity
- Index Tracked
- MSCI EAFE High Dividend Yield
HDEF Summary
HDEF is an ETF that follows the MSCI EAFE High Dividend Yield Index, focusing on companies in developed markets outside North America that pay relatively high dividends. It holds well-known international names like Shell, Nestlé, Novartis, and Unilever, giving investors broad exposure to sectors such as consumer goods, energy, and financials. Someone might invest in HDEF to seek regular income from dividends while diversifying beyond the U.S. market. A key risk is that international stock prices and dividend payments can go up and down with global markets and currency movements.
How much will it cost me?
HDEF has an expense ratio of 0.09%, which means you’ll pay about $0.90 per year for every $1,000 invested. This cost is lower than the average ETF because HDEF is passively managed, tracking an index rather than paying for a team to actively pick stocks.
What would affect this ETF?
HDEF could benefit if developed markets outside North America remain stable or grow, supporting steady profits and dividends from its large holdings in consumer staples, health care, and financial companies like Nestlé, Novartis, and Allianz, and if interest rates fall, making dividend income more attractive. On the negative side, slower economic growth in Europe or Asia, stricter regulations on energy and financial firms, or rising interest rates that make bonds more appealing than dividend stocks could weigh on the ETF’s future performance.
HDEF Top 10 Holdings
HDEF leans heavily on European blue chips, with energy and healthcare names doing most of the heavy lifting. TotalEnergies and Shell have been rising steadily, giving the fund a strong boost from the energy patch, while Roche and Novartis add a healthy dose of momentum from pharma. On the defensive side, consumer staples like Nestlé and Unilever have been more mixed, occasionally losing steam and softening overall returns. With broad exposure across developed markets outside North America, this ETF is essentially a high-dividend play on Europe’s corporate heavyweights.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 GB:SHEL | Shell (UK) | 5.99% | $140.64M | GBP 229.30B | 40.01% | 73Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:NOVN | Novartis AG | 5.10% | $119.71M | CHF 244.89B | 35.30% | 80Outperform |
 CH:NESN | Nestlé SA | 4.81% | $112.88M | CHF 217.87B | 9.36% | 71Outperform |
 DE:ALV | Allianz | 4.32% | $101.46M | EUR 166.13B | 23.20% | 67Neutral |
 FR:TTE | TotalEnergies SE | 4.29% | $100.75M | EUR 190.70B | 59.27% | 78Outperform |
 ES:IBE | Iberdrola | 3.56% | $83.63M | EUR 146.27B | 26.31% | 67Neutral |
 GB:ULVR | Unilever | 3.26% | $76.53M | GBP 104.93B | -6.01% | 72Outperform |
 GB:BATS | British American Tobacco | 2.85% | $67.01M | GBP 98.70B | 17.93% | 71Outperform |
HDEF Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Positive. The current price of 34.38 is above the 20-day moving average (MA) of 33.35, above the 50-day MA of 33.37, and above the 200-day MA of 32.36, indicating a bullish trend. The MACD of 0.32 indicates Negative momentum. The RSI at 67.51 is Neutral, neither overbought nor oversold. The STOCH value of 77.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HDEF.
HDEF Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| HDEF | $34.38 | $36.00(4.71% Upside) | $2.34B | 0.09% | 67Neutral |
 IDV | $42.74 | $47.84(11.92% Upside) | $8.32B | 0.50% | 59Neutral |
 DIVI | $42.37 | $50.80(19.89% Upside) | $2.65B | 0.09% | 66Neutral |
 FGD | $33.66 | $36.48(8.37% Upside) | $1.60B | 0.55% | 58Neutral |
 DTH | $55.70 | $61.96(11.24% Upside) | $635.86M | 0.58% | 61Neutral |
 EFAS | $22.30 | $24.67(10.62% Upside) | $60.56M | 0.55% | 56Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HDEF | Xtrackers MSCI EAFE High Dividend Yield Equity ETF | 34.38 | 6.14 | 21.72% | |
| IDV | iShares International Select Dividend ETF | 42.74 | 7.39 | 20.90% | |
| DIVI | Franklin LibertyQ International Equity Hedged ETF | 42.37 | 5.93 | 16.29% | |
| FGD | First Trust Dow Jones Global Select Dividend Index Fund | 33.66 | 6.23 | 22.70% | |
| DTH | WisdomTree International High Dividend Fund | 55.70 | 8.96 | 19.17% | |
| EFAS | Global X MSCI SuperDividend EAFE ETF | 22.30 | 4.68 | 26.58% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.